ArticleThe oncologist2025
An early relapse prediction model based on pathological features following neoadjuvant immunotherapy for hepatocellular carcinoma.
Yanrui Pang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it